Last reviewed · How we verify

NCT04169620

Effectiveness of a Program With Aquatic Therapy in Patients With Parkinson's Disease Clinical Trial

Status unknown NA Last updated 20 November 2019
What this trial tests

NA trial testing aquatic Ai Chi in Parkinson Disease in 30 participants. Status unknown.

Timeline
7 January 2018
Primary endpoint
30 July 2019
20 December 2019

Quick facts

Lead sponsorUniversidad de Almeria
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date7 January 2018
Primary completion30 July 2019
Estimated completion20 December 2019
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Almeria

Who can join

40 and older, any sex, with Parkinson Disease or Physical Disability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to determine the effect of an aquatic Ai Chi training program on the perception of pain, the maintenance of balance and the functional independence of patients with Parkinson's disease. Fifteen patients diagnosed with Parkinson's disease (Hoehn and Yahr range: 1-3) participated in a program of Aquatic Ai Chi lasting ten weeks with sessions held twice weekly. These were compared to a group of 15 Parkinson patients (control group) who received therapy on dry land.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other Universidad de Almeria trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04169620.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing